Performance evaluation of newly developed surrogate virus neutralization tests for detecting neutralizing antibodies against SARS-CoV-2

Performance evaluation of newly developed surrogate virus neutralization tests for detecting neutralizing antibodies against SARS-CoV-2

Abstract We evaluated newly developed surrogate virus neutralization tests (sVNT) for detecting neutralizing antibodies (NAbs) against the receptor binding domain of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). VERI-Q SARS-CoV-2 Neutralizing Antibody Detection ELISA Kit (MiCo BioMed...

Full description

Bibliographic Details
Main Authors:	Oh Joo Kweon, Joon-Yong Bae, Yong Kwan Lim, Yoojeong Choi, Sohyun Lee, Man-Seong Park, In Bum Suh, Hana Kim, Young Sam Jee, Mi-Kyung Lee
Format:	Article
Language:	English
Published:	Nature Portfolio 2023-03-01
Series:	Scientific Reports
Online Access:	https://doi.org/10.1038/s41598-023-31114-9

Similar Items

Performance Evaluation of the BZ COVID-19 Neutralizing Antibody Test for the Culture-Free and Rapid Detection of SARS-CoV-2 Neutralizing Antibodies
by: Bo Kyeung Jung, et al.
Published: (2021-11-01)

Exploring the vaccine-induced immunity against severe acute respiratory syndrome coronavirus 2 in healthcare workers
by: Yong Kwan Lim, et al.
Published: (2023-04-01)

Performance evaluation of newly developed fluorescence immunoassay-based interferon-gamma release assay for the diagnosis of latent tuberculosis infection in healthcare workers
by: Oh Joo Kweon, et al.
Published: (2022-04-01)

Quantitative SARS-CoV-2 Spike Antibody Response in COVID-19 Patients Using Three Fully Automated Immunoassays and a Surrogate Virus Neutralization Test
by: Yoonjoo Kim, et al.
Published: (2021-08-01)

Detection of SARS-CoV-2 Antibodies: Comparison of Enzyme Immunoassay, Surrogate Neutralization and Virus Neutralization Test
by: Tatjana Vilibic-Cavlek, et al.
Published: (2023-05-01)

Higher correlation between neutralizing antibodies and surrogate neutralizing or binding antibodies in COVID-19 patients than vaccine recipients
by: Hatairat Lerdsamran, et al.
Published: (2024-01-01)

Immuno-Colorimetric Neutralization Test: A Surrogate for Widely Used Plaque Reduction Neutralization Tests in Public Health Virology
by: Sunil R. Vaidya
Published: (2023-04-01)

Homogeneous surrogate virus neutralization assay to rapidly assess neutralization activity of anti-SARS-CoV-2 antibodies
by: Sun Jin Kim, et al.
Published: (2022-07-01)

A surrogate assay for measuring Coxsackievirus A6 neutralizing antibodies
by: Yao Su, et al.
Published: (2018-12-01)

Stochastic neutral drifts seem prevalent in driving human virome assembly: Neutral, near-neutral and non-neutral theoretic analyses
by: Zhanshan (Sam) Ma, et al.
Published: (2022-01-01)

Estimation of SARS-CoV-2 Neutralizing Activity and Protective Immunity in Different Vaccine Types Using Three Surrogate Virus Neutralization Test Assays and Two Semiquantitative Binding Assays Targeting the Receptor-Binding Domain
by: Beomki Lee, et al.
Published: (2022-12-01)

Validation of a SARS-CoV-2 Surrogate Neutralization Test Detecting Neutralizing Antibodies against the Major Variants of Concern
by: Eveline Santos da Silva, et al.
Published: (2023-10-01)

Evaluation of rapid SARS-CoV-2 antigen tests, AFIAS COVID-19 Ag and ichroma COVID-19 Ag, with serial nasopharyngeal specimens from COVID-19 patients.
by: Oh Joo Kweon, et al.
Published: (2021-01-01)

Considerations for the Feasibility of Neutralizing Antibodies as a Surrogate Endpoint for COVID-19 Vaccines
by: Jianyang Liu, et al.
Published: (2022-04-01)

Validation and Establishment of the SARS-CoV-2 Lentivirus Surrogate Neutralization Assay as a Prescreening Tool for the Plaque Reduction Neutralization Test
by: John Merluza, et al.
Published: (2023-02-01)

A Multivariant Surrogate Neutralization Assay Identifies Variant-Specific Neutralizing Antibody Profiles in Primary SARS-CoV-2 Omicron Infection
by: David Niklas Springer, et al.
Published: (2023-07-01)

Structure and Dynamics of the Breast Tissue Microbiomes Under Tumor Influences: An Approach With Neutral, Near-Neutral, and Niche-Neutral Hybrid Models
by: Lianwei Li, et al.
Published: (2021-07-01)

Kinetics of neutralizing antibodies against SARS-CoV-2 infection according to sex, age, and disease severity
by: Yoonjung Kim, et al.
Published: (2022-08-01)

Red and white blood cell morphology characterization and hands-on time analysis by the digital cell imaging analyzer DI-60.
by: Oh Joo Kweon, et al.
Published: (2022-01-01)

Assessing the measurement uncertainty of qualitative analysis in the clinical laboratory
by: Lim Yong Kwan, et al.
Published: (2020-02-01)

Development of a neutralization monoclonal antibody with a broad neutralizing effect against SARS-CoV-2 variants
by: Hae Li Ko, et al.
Published: (2023-12-01)

SARS-CoV-2 Neutralizing Responses in Various Populations, at the Time of SARS-CoV-2 Variant Virus Emergence: Evaluation of Two Surrogate Neutralization Assays in Front of Whole Virus Neutralization Test
by: Stephane Marot, et al.
Published: (2022-12-01)

Measuring Variant-Specific Neutralizing Antibody Profiles after Bivalent SARS-CoV-2 Vaccinations Using a Multivariant Surrogate Virus Neutralization Microarray
by: David Niklas Springer, et al.
Published: (2024-01-01)

A Recombinant Chimeric Cedar Virus-Based Surrogate Neutralization Assay Platform for Pathogenic Henipaviruses
by: Moushimi Amaya, et al.
Published: (2023-04-01)

Evaluation of a multi-species SARS-CoV-2 surrogate virus neutralization test
by: Carmen W.E. Embregts, et al.
Published: (2021-12-01)

Evaluating Humoral Immunity against SARS-CoV-2: Validation of a Plaque-Reduction Neutralization Test and a Multilaboratory Comparison of Conventional and Surrogate Neutralization Assays
by: Emelissa J. Valcourt, et al.
Published: (2021-12-01)

Neutral Education and Neutral Peace Education
by: Francisco Jiménez Bautista
Published: (2019-12-01)

Neutral surfaces in neutral four-spaces
by: Gary Jensen, et al.
Published: (1990-11-01)

BAFF-neutralizing interaction of belimumab related to its therapeutic efficacy for treating systemic lupus erythematosus
by: Woori Shin, et al.
Published: (2018-03-01)

Neutral- and Multi-Colored Semitransparent Perovskite Solar Cells
by: Kyu-Tae Lee, et al.
Published: (2016-04-01)

Clinical performance of SARS-CoV-2 antigen-detection rapid diagnostic test using SERS-based lateral flow immunoassay
by: Sumi Yoon, et al.
Published: (2023-09-01)

MG1141A as a Highly Potent Monoclonal Neutralizing Antibody Against SARS-CoV-2 Variants
by: Sua Lee, et al.
Published: (2021-11-01)

Market neutrality of market neutral hedge funds : contemporaneous and projected neutrality 1998-2007.
by: Lin, Joel Zhihan., et al.
Published: (2008)

Structural basis of HCV neutralization by human monoclonal antibodies resistant to viral neutralization escape.
by: Thomas Krey, et al.
Published: (2013-01-01)

Neutralizing Antibody Response to Hepatitis C Virus
by: Zhen-Yong Keck, et al.
Published: (2011-11-01)

Impact of social distancing on the spread of common respiratory viruses during the coronavirus disease outbreak.
by: Min-Chul Kim, et al.
Published: (2021-01-01)

Performance of a Surrogate SARS-CoV-2-Neutralizing Antibody Assay in Natural Infection and Vaccination Samples
by: Kwok-Hung Chan, et al.
Published: (2021-09-01)

Novel Surrogate Neutralizing Assay Supports Parvovirus B19 Vaccine Development for Children with Sickle Cell Disease
by: Rhiannon R. Penkert, et al.
Published: (2021-08-01)

Validation of a SARS-CoV-2 Surrogate Virus Neutralization Test in Recovered and Vaccinated Healthcare Workers
by: Lina Mouna, et al.
Published: (2023-02-01)

Effect of vaccine dosing intervals on Omicron surrogate neutralization after three doses of BNT162b2
by: Martin A. Prusinkiewicz, et al.
Published: (2023-06-01)